Cancer Diagnostics Global Market Report, Industry Insights, Trends, Key Developments 2017–2023

Tue Dec 5, 2017 - 9:30am GMT+0000

According to Stratistics MRC, the Global Cancer Diagnostics market is expected to grow from $8.54 billion in 2016 to reach $22.41 billion by 2023 with a CAGR of 14.8 %.

Gaithersburg, Maryland, U.S. – December 5, 2017

Access the complete report at: http://www.strategymrc.com/report/cancer-diagnostics-market/toc

Table of Contents

1 Executive Summary

2 Preface
2.1 Abstract
2.2 Stake Holders
2.3 Research Scope
2.4 Research Methodology
2.4.1 Data Mining
2.4.2 Data Analysis
2.4.3 Data Validation
2.4.4 Research Approach
2.5 Research Sources
2.5.1 Primary Research Sources
2.5.2 Secondary Research Sources
2.5.3 Assumptions

3 Market Trend Analysis
3.1 Introduction
3.2 Drivers
3.3 Restraints
3.4 Opportunities
3.5 Threats
3.6 Technology Analysis
3.7 Application Analysis
3.8 End User Analysis
3.9 Emerging Markets
3.10 Futuristic Market Scenario

4 Porters Five Force Analysis
4.1 Bargaining power of suppliers
4.2 Bargaining power of buyers
4.3 Threat of substitutes
4.4 Threat of new entrants
4.5 Competitive rivalry

5 Global Cancer Diagnostics Market, By Technology
5.1 Introduction
5.2 Instrument-Based
5.2.1 Biopsies
5.2.1.1 Needle Biopsy
5.2.1.2 Endoscopic Biopsy
5.2.1.3 Bone Marrow Biopsy
5.2.1.4 Others
5.2.2 Liquid Biopsy
5.2.3 Diagnostic Imaging
5.2.3.1 Mammography
5.2.3.2 Ultrasound
5.2.3.3 Magnetic Resonance Imaging (MRI)
5.2.3.4 Computed Tomography (CT)
5.2.3.5 Positron Emission Tomography (PET)
5.2.3.5.1 Standalone Positron Emission Tomography
5.2.3.5.2 Hybrid Positron Emission Tomography
5.3 Platform-Based Diagnostics
5.3.1 Immunohistochemistry (IHC)
5.3.2 Flow Cytometry
5.3.3 In Situ Hybridization (ISH)
5.3.4 Polymerase Chain Reaction (PCR)
5.3.5 Next-Generation Sequencing (NGS)
5.3.6 Microarrays
5.3.7 Other Technologies
5.4 Tumor Biomarkers Tests
5.4.1 AFP Tests
5.4.2 CA-19 Tests
5.4.3 BRCA Tests
5.4.4 ALK Tests
5.4.5 CEA Tests
5.4.6 KRAS Mutation Tests
5.4.7 HER2 Tests
5.4.8 EGFR Mutation Tests
5.4.9 CTC Tests
5.4.10 PSA Tests
5.4.11 Other Tumor Biomarkers Tests

6 Global Cancer Diagnostics Market, By Application
6.1 Introduction
6.2 Cervical Cancer
6.3 Breast Cancer
6.4 Liver Cancer
6.5 Blood Cancer
6.6 Kidney Cancer
6.7 Colorectal Cancer
6.8 Pancreatic Cancer
6.9 Ovarian Cancer
6.10 Melanoma
6.11 Lung Cancer
6.12 Other Cancers

7 Global Cancer Diagnostics Market, By End User
7.1 Introduction
7.2 Cancer Research Institutes
7.3 Diagnostic Laboratories
7.4 Hospital Associated Labs
7.5 Other End Users

8 Global Cancer Diagnostics Market, By Geography
8.1 Introduction
8.2 North America
8.2.1 US
8.2.2 Canada
8.2.3 Mexico
8.3 Europe
8.3.1 Germany
8.3.2 UK
8.3.3 Italy
8.3.4 France
8.3.5 Spain
8.3.6 Rest of Europe
8.4 Asia Pacific
8.4.1 Japan
8.4.2 China
8.4.3 India
8.4.4 Australia
8.4.5 New Zealand
8.4.6 South Korea
8.4.7 Rest of Asia Pacific
8.5 South America
8.5.1 Argentina
8.5.2 Brazil
8.5.3 Chile
8.5.4 Rest of South America
8.6 Middle East & Africa
8.6.1 Saudi Arabia
8.6.2 UAE
8.6.3 Qatar
8.6.4 South Africa
8.6.5 Rest of Middle East & Africa

9 Key Developments
9.1 Agreements, Partnerships, Collaborations and Joint Ventures
9.2 Acquisitions & Mergers
9.3 New Product Launch
9.4 Expansions
9.5 Other Key Strategies

10 Company Profiling
10.1 Abbott Diagnostics
10.2 Agilent Technologies, Inc.
10.3 Becton, Dickinson and Company
10.4 bioMérieux
10.5 C.R. Bard, Inc.
10.6 F. Hoffmann-La Roche Ltd.
10.7 GE Healthcare (A Subsidiary of General Electric Company)
10.8 Hologic,Inc.
10.9 Illumina, Inc.
10.10 Koninklijke Philips N.V.
10.11 Qiagen
10.12 Roche Diagnostics
10.13 Siemens Healthcare GmbH
10.14 Thermo Fisher Scientific, Inc.

Request for sample here: http://www.strategymrc.com/report/cancer-diagnostics-market/request-sample

What our report offers:
– Market share assessments for the regional and country level segments
– Market share analysis of the top industry players
– Strategic recommendations for the new entrants
– Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
– Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
– Strategic recommendations in key business segments based on the market estimations
– Competitive landscaping mapping the key common trends
– Company profiling with detailed strategies, financials, and recent developments
– Supply chain trends mapping the latest technological advancements

Follow us on Twitter: https://twitter.com/StratisticsMRC
Follow us on LinkedIn at: https://www.linkedin.com/company/stratistics-market-research-consulting-pvt-ltd?trk=mini-profile

About Stratistics MRC
We offer wide spectrum of research and consulting services with in-depth knowledge of different industries. We are known for customized research services, consulting services and Full Time Equivalent (FTE) services in the research world. We explore the market trends and draw our insights with valid assessments and analytical views. We use advanced techniques and tools among the quantitative and qualitative methodologies to identify the market trends.

Our research reports and publications are routed to help our clients to design their business models and enhance their business growth in the competitive market scenario. We have a strong team with hand-picked consultants including project managers, implementers, industry experts, researchers, research evaluators and analysts with years of experience in delivering the complex projects.

Contact Info:
Name: James Lamb
Email: info@strategymrc.com
Organization: Stratistics Market Research Consulting Pvt Ltd
Phone: +1-301-202-5929

LEAVE A REPLY